{"name": "Richter Group",
 "permalink": "richter-group",
 "crunchbase_url": "http://www.crunchbase.com/company/richter-group",
 "homepage_url": "http://www.richter.hu",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Tue Oct 19 06:39:56 UTC 2010",
 "updated_at": "Mon Jul 11 10:44:16 UTC 2011",
 "overview": "\u003Cp\u003ERichter is a leading multinational pharmaceutical company headquartered in Budapest, Hungary. With consolidated sales of approximately \u00e2\u201a\u00ac1 billion (US$1.3 billion) in 2009 and a market capitalization of \u00e2\u201a\u00ac3.2 billion (US$4.3 billion), Richter is one of the largest pharmaceutical companies in Central Eastern Europe. Richter\u00e2\u20ac\u2122s core markets are in Central Eastern Europe and the CIS and it has a growing presence in the US through its strategic partners and in key EU countries through its commercial subsidiaries. The product portfolio of the company covers most therapeutic areas, including cardiovascular, central nervous system and gynaecology. Richter has the largest R\u0026amp;D unit in Central Eastern Europe and its\noriginal research activity focuses exclusively on CNS disorders with main clinical targets being schizophrenia, anxiety, chronic pain and depression. With its widely acknowledged steroid chemistry expertise, Richter is a significant player in the female healthcare field worldwide.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.fiercebiotech.com/story/richter-buys-preglem-461m/2010-10-07?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Richter buys PregLem for up to $461M",
    "acquired_year": 2010,
    "acquired_month": 10,
    "acquired_day": 7,
    "company":
     {"name": "PregLem",
      "permalink": "preglem",
      "image":
       {"available_sizes":
         [[[150,
            67],
           "assets/images/resized/0010/6170/106170v1-max-150x150.jpg"],
          [[167,
            75],
           "assets/images/resized/0010/6170/106170v1-max-250x250.jpg"],
          [[167,
            75],
           "assets/images/resized/0010/6170/106170v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}